Analyst ratings and price targets can significantly influence investor sentiment and stock price. The reiteration of a 'Buy' rating and a $6 price target by HC Wainwright & Co. indicates their positive outlook on Clearside Biomedical, which could lead to increased investor interest and a potential rise in stock price in the short term.